165 related articles for article (PubMed ID: 38873415)
1. Pharmacological mTOR inhibitors in ameliorating Alzheimer's disease: current review and perspectives.
Xie PL; Zheng MY; Han R; Chen WX; Mao JH
Front Pharmacol; 2024; 15():1366061. PubMed ID: 38873415
[TBL] [Abstract][Full Text] [Related]
2. Activation of mTOR: a culprit of Alzheimer's disease?
Cai Z; Chen G; He W; Xiao M; Yan LJ
Neuropsychiatr Dis Treat; 2015; 11():1015-30. PubMed ID: 25914534
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer's disease and vascular cognitive impairment.
Van Skike CE; Jahrling JB; Olson AB; Sayre NL; Hussong SA; Ungvari Z; Lechleiter JD; Galvan V
Am J Physiol Heart Circ Physiol; 2018 Apr; 314(4):H693-H703. PubMed ID: 29351469
[TBL] [Abstract][Full Text] [Related]
4. Microglial mTOR Activation Upregulates Trem2 and Enhances β-Amyloid Plaque Clearance in the
Shi Q; Chang C; Saliba A; Bhat MA
J Neurosci; 2022 Jul; 42(27):5294-5313. PubMed ID: 35672148
[TBL] [Abstract][Full Text] [Related]
5. Trilateral association of autophagy, mTOR and Alzheimer's disease: Potential pathway in the development for Alzheimer's disease therapy.
Subramanian A; Tamilanban T; Alsayari A; Ramachawolran G; Wong LS; Sekar M; Gan SH; Subramaniyan V; Chinni SV; Izzati Mat Rani NN; Suryadevara N; Wahab S
Front Pharmacol; 2022; 13():1094351. PubMed ID: 36618946
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
7. mTOR Attenuation with Rapamycin Reverses Neurovascular Uncoupling and Memory Deficits in Mice Modeling Alzheimer's Disease.
Van Skike CE; Hussong SA; Hernandez SF; Banh AQ; DeRosa N; Galvan V
J Neurosci; 2021 May; 41(19):4305-4320. PubMed ID: 33888602
[TBL] [Abstract][Full Text] [Related]
8. Magnolol improves Alzheimer's disease-like pathologies and cognitive decline by promoting autophagy through activation of the AMPK/mTOR/ULK1 pathway.
Wang X; Jia J
Biomed Pharmacother; 2023 May; 161():114473. PubMed ID: 36889111
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin, Autophagy, and Alzheimer's Disease.
Cai Z; Yan LJ
J Biochem Pharmacol Res; 2013 Jun; 1(2):84-90. PubMed ID: 23826514
[TBL] [Abstract][Full Text] [Related]
10. Role of PIM Kinase Inhibitor in the Treatment of Alzheimer's Disease.
Meur S; Mukherjee S; Roy S; Karati D
Mol Neurobiol; 2024 May; ():. PubMed ID: 38816674
[TBL] [Abstract][Full Text] [Related]
11. Geniposide-mediated protection against amyloid deposition and behavioral impairment correlates with downregulation of mTOR signaling and enhanced autophagy in a mouse model of Alzheimer's disease.
Zhang Z; Wang X; Zhang D; Liu Y; Li L
Aging (Albany NY); 2019 Jan; 11(2):536-548. PubMed ID: 30684442
[TBL] [Abstract][Full Text] [Related]
12. Neurological Mechanisms of Animal-Assisted Intervention in Alzheimer's Disease: A Hypothetical Review.
Kim S; Nam Y; Ham MJ; Park C; Moon M; Yoo DH
Front Aging Neurosci; 2021; 13():682308. PubMed ID: 34335229
[TBL] [Abstract][Full Text] [Related]
13. Wogonin increases β-amyloid clearance and inhibits tau phosphorylation via inhibition of mammalian target of rapamycin: potential drug to treat Alzheimer's disease.
Zhu Y; Wang J
Neurol Sci; 2015 Jul; 36(7):1181-8. PubMed ID: 25596147
[TBL] [Abstract][Full Text] [Related]
14. Pim1 inhibition as a novel therapeutic strategy for Alzheimer's disease.
Velazquez R; Shaw DM; Caccamo A; Oddo S
Mol Neurodegener; 2016 Jul; 11(1):52. PubMed ID: 27412291
[TBL] [Abstract][Full Text] [Related]
15. p110δ PI3-Kinase Inhibition Perturbs APP and TNFα Trafficking, Reduces Plaque Burden, Dampens Neuroinflammation, and Prevents Cognitive Decline in an Alzheimer's Disease Mouse Model.
Martínez-Mármol R; Mohannak N; Qian L; Wang T; Gormal RS; Ruitenberg MJ; Vanhaesebroeck B; Coulson EJ; Meunier FA
J Neurosci; 2019 Oct; 39(40):7976-7991. PubMed ID: 31363064
[TBL] [Abstract][Full Text] [Related]
16. Interactions between Beta-Amyloid and Pericytes in Alzheimer's Disease.
Li YY; Guo DD; Duan RN; Li Y
Front Biosci (Landmark Ed); 2024 Apr; 29(4):136. PubMed ID: 38682184
[TBL] [Abstract][Full Text] [Related]
17. Artemether Attenuates Aβ25-35-Induced Cognitive Impairments by Downregulating Aβ, BACE1, mTOR and Tau Proteins.
Li HJ; Wang TZ; Hou C; Liu HY; Zhang Y; Xue ZZ; Cai QC; Chen DM; Gao CW; Yang JL; Cong L; Chen Y; Yao Q; Zhu QS; Cao C
Clin Lab; 2021 Oct; 67(10):. PubMed ID: 34655202
[TBL] [Abstract][Full Text] [Related]
18. Carbon dots as dual inhibitors of tau and amyloid-beta aggregation for the treatment of Alzheimer's disease.
Zhang W; Smith N; Zhou Y; McGee CM; Bartoli M; Fu S; Chen J; Domena JB; Joji A; Burr H; Lv G; Cilingir EK; Bedendo S; Claure ML; Tagliaferro A; Eliezer D; Veliz EA; Zhang F; Wang C; Leblanc RM
Acta Biomater; 2024 Jun; ():. PubMed ID: 38849023
[TBL] [Abstract][Full Text] [Related]
19. Reversing pathology in a preclinical model of Alzheimer's disease by hacking cerebrovascular neoangiogenesis with advanced cancer therapeutics.
Singh CSB; Choi KB; Munro L; Wang HY; Pfeifer CG; Jefferies WA
EBioMedicine; 2021 Sep; 71():103503. PubMed ID: 34534764
[TBL] [Abstract][Full Text] [Related]
20. Autophagic dysfunction in Alzheimer's disease: Cellular and molecular mechanistic approaches to halt Alzheimer's pathogenesis.
Uddin MS; Mamun AA; Labu ZK; Hidalgo-Lanussa O; Barreto GE; Ashraf GM
J Cell Physiol; 2019 Jun; 234(6):8094-8112. PubMed ID: 30362531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
